Publication Results

Generate Report

Add publications by marking their checkboxes, or

Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.

Szczepanek CM,  Hurley P,  Good MJ,  Denicoff A,  Willenberg K,  Dawson C,  Kurbegov D
J Oncol Pract 2017 Jun;13(6):395-400
PubMed ID: 28481681
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Majithia N,  Temkin SM,  Ruddy KJ,  Beutler AS,  Hershman DL,  Loprinzi CL
Support Care Cancer 2016 Mar;24(3):1439-47
PubMed ID: 26686859
PMC ID: PMC5078987
Groups or Programs: Community Oncology and Prevention TrialsSupportive and Palliative Care

Results from NRG oncology/NSABP protocol DMP-1: Women's decision-making in breast cancer risk reduction

Holmberg C,  Bandos H,  Fagerlin A,  Bevers T B,  Battaglia T A,  Wickerham D L,  McCaskill-Stevens W
Cancer Res 2016 Feb 15;76(Suppl 4)
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.

Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS,  Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS
J Oncol Pract 2016 Jan;12(1):63-35
PubMed ID: 26627979
PMC ID: PMC4976452
Groups or Programs: Community Oncology and Prevention Trials

A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity.

Plank-Bazinet JL,  Kornstein SG,  Clayton JA,  McCaskill-Stevens W,  Wood L,  Cook N,  Tajuddin SM,  Brown GM,  Harris T,  Evans MK,  Begg L,  Brooks CE,  Miller LR,  Mistretta AC,  Cornelison TL
J Womens Health (Larchmt) 2016 Jan;25(1):4-10
PubMed ID: 26771559
PMC ID: PMC4741201
Groups or Programs: Community Oncology and Prevention Trials

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.

Sagae S,  Monk BJ,  Pujade-Lauraine E,  Gaffney DK,  Narayan K,  Ryu SY,  McCormack M,  Plante M,  Casado A,  Reuss A,  Chávez-Blanco A,  Kitchener H,  Nam BH,  Jhingran A,  Temkin S,  Mileshkin L,  Berns E,  Scholl S,  Doll C,  Abu-Rustum NR,  Lecuru F,  Small W Jr,  Gynecologic Cancer InterGroup Cervix Cancer brainstorming day
Int J Gynecol Cancer 2016 Jan;26(1):199-207
PubMed ID: 26569057
PMC ID: PMC4831060
Groups or Programs: Community Oncology and Prevention Trials

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

Ligibel JA,  Alfano CM,  Hershman D,  Ballard RM,  Bruinooge SS,  Courneya KS,  Daniels EC,  Demark-Wahnefried W,  Frank ES,  Goodwin PJ,  Irwin ML,  Levit LA,  McCaskill-Stevens W,  Minasian LM,  O'Rourke MA,  Pierce JP,  Stein KD,  Thomson CA,  Hudis CA
J Clin Oncol 2015 Nov 20;33(33):3961-7
PubMed ID: 26324364
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director

My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).

Holmberg C,  Waters EA,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Med Decis Making 2015 Nov;35(8):1010-22
PubMed ID: 26183166
PMC ID: PMC4592416
Groups or Programs: Community Oncology and Prevention Trials

Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study.

Holmberg C,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Sociol Health Illn 2015 Nov;37(8):1373-87
PubMed ID: 26235092
PMC ID: PMC4609249
Groups or Programs: Community Oncology and Prevention Trials

A cluster-randomized study of clinician-patient shared vs standard reporting of symptomatic adverse events using PRO-CTCAE nested in a multicenter trial of multimodal therapy for rectal cancer (Alliance N1048 PROSPECT)

Dueck Amylou C.,  Mitchell Sandra A.,  Rogak Lauren J.,  Ginos Brenda,  Sargent Daniel J.,  Shi Qian,  Farma Jeffrey M.,  Eng Cathy,  Crane Christopher,  Kennecke Hagen,  O'Mara Ann M.,  Minasian Lori M.,  Schrag Deborah,  Basch Ethan
Qual Life Res 2015 Oct 1;24(1 Suppl):1-2
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive and Palliative Care

Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.

Temkin SM,  Seibel NL
Cancer 2015 Oct 1;121(19):3395-402
PubMed ID: 26110510
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Cooperative Group Trials in the Community Setting.

Lloyd Wade J 3rd,  Petrelli NJ,  McCaskill-Stevens W
Semin Oncol 2015 Oct;42(5):686-92
PubMed ID: 26433550
PMC ID: PMC4692715
Groups or Programs: Community Oncology and Prevention Trials

Casing uncertainty in LCIS recommendations through two patient narratives

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Battaglia Tracy A.,  Bevers Therese B.,  McCaskill-Stevens Worta,  Mueller-Nordhorn Jacqueline,  Holmberg Christine
Eur J Cancer Care 2015 Sep 1;24(Suppl 2):32-32
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology.

Kent EE,  Mitchell SA,  Castro KM,  DeWalt DA,  Kaluzny AD,  Hautala JA,  Grad O,  Ballard RM,  McCaskill-Stevens WJ,  Kramer BS,  Clauser SB
J Clin Oncol 2015 Aug 20;33(24):2705-11
PubMed ID: 26195715
PMC ID: PMC4559611
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director

Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.

Dimond EP,  St Germain D,  Nacpil LM,  Zaren HA,  Swanson SM,  Minnick C,  Carrigan A,  Denicoff AM,  Igo KE,  Acoba JD,  Gonzalez MM,  McCaskill-Stevens W
Clin Trials 2015 Jun;12(3):246-56
PubMed ID: 25691600
PMC ID: PMC4420772
Groups or Programs: Community Oncology and Prevention Trials

Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.

Temkin SM,  Fleming SA,  Amrane S,  Schluterman N,  Terplan M
Gynecol Oncol 2015 Jun;137(3):497-502
PubMed ID: 25795262
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Decision-making in breast cancer risk reduction: Results from a nested qualitative study from NRG Oncology/NSABP protocol DMP-1

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Bevers Therese Bartholomew,  Battaglia Tracy Ann,  Fagerlin Angela,  McCaskill-Stevens Worta J.,  Holmberg Christine
J Clin Oncol 2015 May 20;33(15):Abstract e17569
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Creating a national collaborative strategy to enhance trial accrual in NCI's National Clinical Trials Network (NCTN) in the era of precision medicine

Denicoff Andrea,  Massett Holly A.,  Mishkin Grace E.,  Bangs Rick,  Berlin Jordan,  Bischoff Miriam B.,  DeSanto Frank,  Duli Anne,  Horvath Laura E.,  Katz Michael S.,  Lambersky Ruth,  Mann Bhupinder Singh,  McCaskill-Stevens Worta J.,  Seibel Nita,  Stine Sharon Hartson,  Williams Wade,  Mooney Margaret M.,  Abrams Jeffrey S.
J Clin Oncol 2015 May 20;33(15):Abstract 6589
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

"Less is more:" The harms of overtreatment in early ovarian cancer.

Temkin SM
Gynecol Oncol 2015 May;137(2):191-2
PubMed ID: 25953509
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Generalizability of established prostate cancer risk variants in men of African ancestry.

Han Y,  Signorello LB,  Strom SS,  Kittles RA,  Rybicki BA,  Stanford JL,  Goodman PJ,  Berndt SI,  Carpten J,  Casey G,  Chu L,  Conti DV,  Rand KA,  Diver WR,  Hennis AJ,  John EM,  Kibel AS,  Klein EA,  Kolb S,  Le Marchand L,  Leske MC,  Murphy AB,  Neslund-Dudas C,  Park JY,  Pettaway C,  Rebbeck TR,  Gapstur SM,  Zheng SL,  Wu SY,  Witte JS,  Xu J,  Isaacs W,  Ingles SA,  Hsing A,  PRACTICAL Consortium,  ELLIPSE GAME-ON Consortium,  Easton DF,  Eeles RA,  Schumacher FR,  Chanock S,  Nemesure B,  Blot WJ,  Stram DO,  Henderson BE,  Haiman CA
Int J Cancer 2015 Mar 1;136(5):1210-7
PubMed ID: 25044450
PMC ID: PMC4268262
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

What is cancer nursing research?

O'Mara A
Cancer Nurs 2015 Mar-Apr;38(2):81-2
PubMed ID: 25689041
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG,  Glynn RJ,  Gaziano JM,  Darke AK,  Crowley JJ,  Goodman PJ,  Lippman SM,  Lad TE,  Bearden JD,  Goodman GE,  Minasian LM,  Thompson IM Jr,  Blanke CD,  Klein EA
JAMA Ophthalmol 2015 Jan;133(1):17-24
PubMed ID: 25232809
PMC ID: PMC4395006
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

Arnold KB,  Hermos JA,  Anderson KB,  Minasian L,  Tangen CM,  Probstfield JF,  Cook ED
Cancer Epidemiol Biomarkers Prev 2014 Dec;23(12):2895-905
PubMed ID: 25242051
PMC ID: PMC4257858
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Jacobs SR,  Weiner BJ,  Reeve BB,  Weinberger M,  Minasian LM,  Good MJ
Clin Trials 2014 Oct;11(5):565-75
PubMed ID: 24902923
PMC ID: PMC4156916
Groups or Programs: Community Oncology and Prevention Trials

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y,  Ketchum NS,  Goodman PJ,  Klein EA,  Thompson IM Jr
J Urol 2014 Oct;192(4):1094-9
PubMed ID: 24747090
PMC ID: PMC4194238
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Albanes D,  Till C,  Klein EA,  Goodman PJ,  Mondul AM,  Weinstein SJ,  Taylor PR,  Parnes HL,  Gaziano JM,  Song X,  Fleshner NE,  Brown PH,  Meyskens FL Jr,  Thompson IM
Cancer Prev Res (Phila) 2014 Sep;7(9):886-95
PubMed ID: 24961880
PMC ID: PMC4408535
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe FL,  Appleby PN,  Travis RC,  Barnett M,  Brasky TM,  Bueno-de-Mesquita HB,  Chajes V,  Chavarro JE,  Chirlaque MD,  English DR,  Gibson RA,  Giles GG,  Goodman GE,  Henning SM,  Kaaks R,  King IB,  Kolonel LN,  Kristal AR,  Neuhouser ML,  Park SY,  Severi G,  Siddiq A,  Stampfer MJ,  Stattin P,  Tangen CM,  Tjønneland A,  Trichopoulos D,  Tumino R,  Wilkens LR,  Key TJ,  Allen NE,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2014 Sep;106(9)
PubMed ID: 25210201
PMC ID: PMC4188122
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Martinez EE,  Darke AK,  Tangen CM,  Goodman PJ,  Fowke JH,  Klein EA,  Abdulkadir SA
Cancer Prev Res (Phila) 2014 Sep;7(9):950-7
PubMed ID: 24894197
PMC ID: PMC4154984
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.

Shelburne N,  Adhikari B,  Brell J,  Davis M,  Desvigne-Nickens P,  Freedman A,  Minasian L,  Force T,  Remick SC
J Natl Cancer Inst 2014 Sep;106(9)
PubMed ID: 25210198
PMC ID: PMC4176042
Groups or Programs: Community Oncology and Prevention TrialsSupportive and Palliative Care

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM,  Rizzato C,  Kraft P,  Kooperberg C,  Petersen GM,  Wang Z,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Buring J,  Canzian F,  Duell EJ,  Gallinger S,  Giles GG,  Goodman GE,  Goodman PJ,  Jacobs EJ,  Kamineni A,  Klein AP,  Kolonel LN,  Kulke MH,  Li D,  Malats N,  Olson SH,  Risch HA,  Sesso HD,  Visvanathan K,  White E,  Zheng W,  Abnet CC,  Albanes D,  Andreotti G,  Austin MA,  Barfield R,  Basso D,  Berndt SI,  Boutron-Ruault MC,  Brotzman M,  Büchler MW,  Bueno-de-Mesquita HB,  Bugert P,  Burdette L,  Campa D,  Caporaso NE,  Capurso G,  Chung C,  Cotterchio M,  Costello E,  Elena J,  Funel N,  Gaziano JM,  Giese NA,  Giovannucci EL,  Goggins M,  Gorman MJ,  Gross M,  Haiman CA,  Hassan M,  Helzlsouer KJ,  Henderson BE,  Holly EA,  Hu N,  Hunter DJ,  Innocenti F,  Jenab M,  Kaaks R,  Key TJ,  Khaw KT,  Klein EA,  Kogevinas M,  Krogh V,  Kupcinskas J,  Kurtz RC,  LaCroix A,  Landi MT,  Landi S,  Le Marchand L,  Mambrini A,  Mannisto S,  Milne RL,  Nakamura Y,  Oberg AL,  Owzar K,  Patel AV,  Peeters PH,  Peters U,  Pezzilli R,  Piepoli A,  Porta M,  Real FX,  Riboli E,  Rothman N,  Scarpa A,  Shu XO,  Silverman DT,  Soucek P,  Sund M,  Talar-Wojnarowska R,  Taylor PR,  Theodoropoulos GE,  Thornquist M,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Vodicka P,  Wactawski-Wende J,  Wentzensen N,  Wu C,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Hoover R,  Hartge P,  Fuchs C,  Chanock SJ,  Stolzenberg-Solomon RS,  Amundadottir LT
Nat Genet 2014 Sep;46(9):994-1000
PubMed ID: 25086665
PMC ID: PMC4191666
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Clinical research education: perspectives of nurses, employers, and educators.

Galassi AL,  Grady MA,  O'Mara AM,  Ness EA,  Parreco LK,  Belcher AE,  Hastings CE
J Nurs Educ 2014 Aug;53(8):466-72
PubMed ID: 25050563
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER,  Arnold KB,  Moinpour CM,  Burton-Chase AM,  Tangen CM,  Probstfield JF,  See WA,  Lieber MM,  Caggiano V,  Moody-Thomas S,  Szczepanek C,  Ryan A,  Carlin S,  Hill S,  Goodman PJ,  Padberg RM,  Minasian LM,  Meyskens FL,  Thompson IM Jr
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48
PubMed ID: 25028457
PMC ID: PMC4119542
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Community Clinical Oncology Program (CCOP) ;  Prostate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.

Kristal AR,  Till C,  Song X,  Tangen CM,  Goodman PJ,  Neuhauser ML,  Schenk JM,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Klein EA
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1494-504
PubMed ID: 24732629
PMC ID: PMC4119495
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

Platz EA,  Tangen CM,  Goodman PJ,  Till C,  Parnes HL,  Figg WD,  Albanes D,  Neuhouser ML,  Klein EA,  Lucia MS,  Thompson IM Jr,  Kristal AR
J Urol 2014 Aug;192(2):379-84
PubMed ID: 24518774
PMC ID: PMC4104140
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Schenk JM,  Till CA,  Tangen CM,  Goodman PJ,  Song X,  Torkko KC,  Kristal AR,  Peters U,  Neuhouser ML
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1484-93
PubMed ID: 25085836
PMC ID: PMC4120235
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Figg WD,  Chau CH,  Price DK,  Till C,  Goodman PJ,  Cho Y,  Varella-Garcia M,  Reichardt JK,  Tangen CM,  Leach RJ,  van Bokhoven A,  Thompson IM,  Lucia MS
Urology 2014 Jul;84(1):127-31
PubMed ID: 24824408
PMC ID: PMC4077907
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Reeve BB,  Mitchell SA,  Dueck AC,  Basch E,  Cella D,  Reilly CM,  Minasian LM,  Denicoff AM,  O'Mara AM,  Fisch MJ,  Chauhan C,  Aaronson NK,  Coens C,  Bruner DW
J Natl Cancer Inst 2014 Jul;106(7)
PubMed ID: 25006191
PMC ID: PMC4110472
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP,  Hoefler J,  Bock S,  Goodman PJ,  Vickers A,  Hernandez J,  Sokoll LJ,  Sanda MG,  Wei JT,  Leach RJ,  Thompson IM
Urology 2014 Jun;83(6):1362-7
PubMed ID: 24862395
PMC ID: PMC4035700
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Gurel B,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Tangen CM,  Kristal AR,  Parnes HL,  Hoque A,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2014 May;23(5):847-56
PubMed ID: 24748218
PMC ID: PMC4012292
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.

Langford AT,  Resnicow K,  Dimond EP,  Denicoff AM,  Germain DS,  McCaskill-Stevens W,  Enos RA,  Carrigan A,  Wilkinson K,  Go RS
Cancer 2014 Mar 15;120(6):877-84
PubMed ID: 24327389
PMC ID: PMC3947654
Groups or Programs: Community Oncology and Prevention Trials

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR,  Darke AK,  Morris JS,  Tangen CM,  Goodman PJ,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Lippman SM,  Klein EA
J Natl Cancer Inst 2014 Mar;106(3):djt456
PubMed ID: 24563519
PMC ID: PMC3975165
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

St Germain D,  Denicoff AM,  Dimond EP,  Carrigan A,  Enos RA,  Gonzalez MM,  Wilkinson K,  Mathiason MA,  Duggan B,  Einolf S,  McCaskill-Stevens W,  Bryant DM,  Thompson MA,  Grubbs SS,  Go RS
J Oncol Pract 2014 Mar;10(2):e73-80
PubMed ID: 24424313
PMC ID: PMC3948711
Groups or Programs: Community Oncology and Prevention Trials

Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors.

Fisch MJ,  Zhao F,  O'Mara AM,  Wang XS,  Cella D,  Cleeland CS
Cancer 2014 Feb 1;120(3):442-50
PubMed ID: 24151111
PMC ID: PMC4134680
Groups or Programs: Community Oncology and Prevention Trials

Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.

Wang XS,  Zhao F,  Fisch MJ,  O'Mara AM,  Cella D,  Mendoza TR,  Cleeland CS
Cancer 2014 Feb 1;120(3):425-32
PubMed ID: 24436136
PMC ID: PMC3949157
Groups or Programs: Community Oncology and Prevention Trials

Nurse scientists in cancer cooperative groups.

Bruner DW,  O'Mara A
Semin Oncol Nurs 2014 Feb;30(1):4-10
PubMed ID: 24559774
PMC ID: not available
Groups or Programs: Community Oncology and Prevention Trials

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Hay JL,  Atkinson TM,  Reeve BB,  Mitchell SA,  Mendoza TR,  Willis G,  Minasian LM,  Clauser SB,  Denicoff A,  O'Mara A,  Chen A,  Bennett AV,  Paul DB,  Gagne J,  Rogak L,  Sit L,  Viswanath V,  Schrag D,  Basch E,  NCI PRO-CTCAE Study Group
Qual Life Res 2014 Feb;23(1):257-69
PubMed ID: 23868457
PMC ID: PMC3896507
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.

Cleeland CS,  Zhao F,  Chang VT,  Sloan JA,  O'Mara AM,  Gilman PB,  Weiss M,  Mendoza TR,  Lee JW,  Fisch MJ
Cancer 2013 Dec 15;119(24):4333-40
PubMed ID: 24114037
PMC ID: PMC3860266
Groups or Programs: Community Oncology and Prevention Trials

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

Karp DD,  Lee SJ,  Keller SM,  Wright GS,  Aisner S,  Belinsky SA,  Johnson DH,  Johnston MR,  Goodman G,  Clamon G,  Okawara G,  Marks R,  Frechette E,  McCaskill-Stevens W,  Lippman SM,  Ruckdeschel J,  Khuri FR
J Clin Oncol 2013 Nov 20;31(33):4179-87
PubMed ID: 24002495
PMC ID: PMC3821010
Groups or Programs: Community Oncology and Prevention Trials

Survival in the prostate cancer prevention trial.

Tangen CM,  Goodman PJ,  Thompson IM Jr
N Engl J Med 2013 Nov 14;369(20):1968
PubMed ID: 24224632
PMC ID: PMC4927191
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score.

Ankerst DP,  Till C,  Boeck A,  Goodman PJ,  Tangen CM,  Thompson IM
Urology 2013 Nov;82(5):1076-81
PubMed ID: 24055241
PMC ID: PMC3874369
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)